A study in glioma demonstrated that high levels of IRAK1 bound to and prevented the degradation of PRDX1, a major member of antioxidant enzymes, in glioma cells, leading to the suppression of autophagic cell death and development of radioresistance. The gene discussed is IRAK1; the disease is central nervous system cancer.